Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9434974 | Neuroscience Research | 2005 | 9 Pages |
Abstract
We investigated the role of IL-1α and IL-1β expressed in the reactive gliosis following hippocampal damage induced by trimethyltin (TMT). IL-1α immunoreactivity was expressed earlier in small glial cells on day 4 post-TMT, while IL-1β expression was obvious in large swollen glial cells on day 14 post-TMT. Both IL-1α and IL-1β immunoreactivities were double-labeled with astrocyte marker, vimentin, but not with a microglia marker, OX-42. The expression of both IL-1α/β was enhanced by adrenalectomy (ADX) prior to TMT administration. Corticosterone (CORT) or dexamethasone (DEX) supplementation not only cancelled effects of ADX, but also partially reversed TMT-induced enhancement of IL-1α/β expressions. These changes coincided with TMT-induced neuronal death in CA3 pyramidal cells of the hippocampus. It is suggested that IL-1α/β expressed in reactive astrocytes participate in TMT neurotoxicity via type II glucocorticoid receptors.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Y. Liu, H. Imai, M. Sadamatsu, K. Tsunashima, N. Kato,